Menu
Recruiting NCT07481864

The Effect of Early-Phase Graded Motor Imagery Following Massive Rotator Cuff Repair.

No phase Interventional Shoulder Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Graded Motor İmagery.
Who it may be relevant to
Registry conditions: Shoulder Pain. Basic parameters: 30 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effect of Early-Phase Graded Motor Imagery Following Massive Rotator Cuff Repair

Overview

Massive rotator cuff tears are associated with significant pain, functional limitations, and prolonged rehabilitation following surgical repair. In the early postoperative phase, rehabilitation protocols are often limited due to surgical protection requirements, which may delay the restoration of motor control and shoulder function. Graded motor imagery (GMI), a movement representation technique that includes laterality recognition, motor imagery, and mirror therapy, has been shown to modulate cortical processing and improve pain and motor function in various musculoskeletal and neurological conditions. However, its potential role in early postoperative shoulder rehabilitation has not been adequately investigated.

Interventions

  • Other Graded Motor İmagery
    The graded motor imagery program will include laterality recognition training, motor imagery exercises, and mirror therapy tasks aimed at activating cortical motor networks without physical shoulder movement during the early postoperative phase.

Primary outcome measures

  • Pain Intensity (Numeric Rating Scale, NRS) [Time frame: Baseline (postoperative day 0), 2 weeks, 4 weeks, 6 weeks, and 12 weeks after surgery.]
  • Subjective Shoulder Value (SSV) [Time frame: Baseline (postoperative day 0), 2 weeks, 4 weeks, 6 weeks, and 12 weeks.]
  • Passive Shoulder Range of Motion [Time frame: 4 weeks, 6 weeks, and 12 weeks after surgery.]
Secondary outcome measures (5)
  • Shoulder Pain and Disability Index (SPADI) [Time frame: 6 weeks and 12 weeks after surgery.]
  • Motor Imagery Ability (VMIQ-2) [Time frame: Baseline (postoperative day 0), 6 weeks, and 12 weeks.]
  • Tampa Scale of Kinesiophobia (TSK) [Time frame: Baseline (postoperative day 0), 6 weeks, and 12 weeks.]
  • Pain Catastrophizing Scale (PCS) [Time frame: Baseline (postoperative day 0), 6 weeks, and 12 weeks.]
  • Pain Self-Efficacy Questionnaire (PSEQ) [Time frame: Baseline (postoperative day 0), 6 weeks, and 12 weeks.]

Eligibility criteria

Inclusion criteria

  • Age between 30 and 65 years
  • Presence of an arthroscopically repaired anterior-superior rotator cuff tear, involving the supraspinatus and subscapularis tendons

Exclusion criteria

  • Age younger than 30 years or older than 65 years
  • Presence of severe malignant, hematological, endocrine, metabolic, rheumatologic, or gastrointestinal diseases
  • Diagnosis of glenohumeral osteoarthritis (Kellgren-Lawrence grade III or higher, with radiographic evidence of osteophytes)
  • Current treatment with cytotoxic agents or systemic corticosteroids
  • Alcohol dependence, history of substance abuse, or psychological/emotional disorders that may compromise the validity of informed consent
  • Previous surgery on the ipsilateral shoulder
  • Multiple tendon tears, such as combined tears involving the supraspinatus together with the infraspinatus or subscapularis tendons

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Acibadem University — Istanbul

Identifiers

NCT: NCT07481864 · 2025-10-384

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗